According to projections by the Food and Agriculture Organization of the United Nations, the global population will reach 9 billion by 2050. This raises concerns about the ability to feed such a population. In view of the above, it is necessary to search for alternative food sources. Edible insects are rich in complete protein, essential fatty acids, vitamins and micronutrients. Despite this, entomophagy is not common in Europe. In 2021, the European Union approved Acheta domesticus, Tenebrio molitor, Locusta migratoria, and Alphitobius diaperinus for consumption. However, their consumption may also be associated with certain hazards, e.g., food allergies. The purpose of this review is to present existing knowledge, discuss the possible dangers of consuming insects, and identify areas for further research. Studies in Asian populations indicate that edible insects may be responsible for 4.2–19.4% of food allergies and 18% of fatal food-induced anaphylaxis. There are also increasing reports from Europe of food allergies to edible insects. A thorough understanding of allergens, their properties, and the mechanisms of food allergies associated with edible insects’ consumption is essential for ensuring consumers’ safety. In the future, it would be worthwhile to investigate the effects of heat treatment on the allergenicity of insect proteins.
Purpose of review: Allergic rhinitis affects up to one-quarter of the population in industrialized countries. This chronic inflammatory disease of the nasal mucosa is triggered by allergen exposure and mediated by immunoglobulin E, leading to immune dysregulation. Diagnosis typically relies upon skin prick tests, serum-specific immunoglobulin E levels and nasal allergen provocations. Differentiation from non-allergic rhinitis remains a diagnostic challenge. Recent research has identified novel microRNAs, small non-coding RNA regulating post-transcriptional gene expression, as key regulators of immunological pathways with great potential as disease-specific targets in diagnostics and therapy. The purpose of this review is to explore novel therapeutic and diagnostic possibilities regarding novel miRNAs. Recent findings: This functional review evaluated current evidence specific to miRNA expression in allergic and non-allergic rhinitis. Seven microRNAs (miR-29a, miR-135a, miR-143, miR-146a, miR-150-5p, miR-223, miR-451) are discussed as potential diagnostic markers and therapeutic agents in the future. Interventional studies, including human and animal studies, are reviewed. The available evidence suggested that selected microRNAs may show specificity and sensitivity as biomarkers for allergic and non-allergic rhinitis in future human trials. Therapeutic options involving miRNAs have shown great promise but still lack validation in clinical studies. In this review, we have identified several challenges in microRNA-based diagnostic approaches and suggested strategies to facilitate future development. Summary: MiRNA research in AR has revealed their role as both diagnostic biomarkers and therapeutic agents in several different mechanisms that are currently under investigation. Dysregulation of miRNA expression has been documented in asthma and allergic rhinitis, but data regarding non-allergic rhinitis remain limited.
The present work describes the protolytic properties and in vitro biological activity of spinorphin (Leu-Val-Val-Tyr-Pro-Trp-Thr) and three spinorphin derivatives containing butyric acid residue: Butyryl-Lys-Lys-Leu-Leu-Val-Tyr-Pro-Trp-Thr, Butyryl-Lys-Lys-Leu-Val-Val-Tyr-Pro-Trp-Thr (butyric acid bound to the α-amino group of lysine), Lys(Butyryl)-Lys-Leu-Val-Val-Tyr-Pro-Trp-Thr (butyric acid bound to the ε-amino group of lysine) in an aqueous solution. The overall protonation constants and the stepwise dissociation constants of the ligands studied were calculated by the potentiometric method. The percentage of each species formed was estimated from the species distribution curves as a function of pH. The biological activity of all tested compounds was characterized in vitro, in the neutral red uptake and Griess assay tests in RAW264.7 macrophage cell line. The three protonation constants for spinorphin and four for its derivatives suggest that metal ions may bind to these peptides and form complexes by coordination with the functional groups of the respective amino acid residues. In vitro biological activity tests suggest that two peptides deserve attention for their potential anti-inflammatory role.